Anti-BRAF antibody [EP152Y] (ab33899) is a rabbit monoclonal antibody that is used to detect BRAF in Western Blot, IP, IHC-P. Suitable for Human, Mouse, Rat samples.
- Specificity confirmed with BRAF knockout cell line validation
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IP | WB | IHC-P | ICC | |
---|---|---|---|---|
Human | Tested | Tested | Tested | Not recommended |
Mouse | Expected | Tested | Expected | Not recommended |
Rat | Expected | Tested | Expected | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/20 | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/1000 - 1/5000 | Notes - |
Species Rat | Dilution info 1/1000 - 1/5000 | Notes - |
Species Human | Dilution info 1/1000 - 1/5000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100 | Notes The mouse and rat recommendation is based on the WB results. We do not guarantee IHC-P for mouse and rat. Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Select an associated product type
Protein kinase involved in the transduction of mitogenic signals from the cell membrane to the nucleus (Probable). Phosphorylates MAP2K1, and thereby activates the MAP kinase signal transduction pathway (PubMed:21441910, PubMed:29433126). Phosphorylates PFKFB2 (PubMed:36402789). May play a role in the postsynaptic responses of hippocampal neurons (PubMed:1508179).
BRAF1, RAFB1, BRAF, Serine/threonine-protein kinase B-raf, Proto-oncogene B-Raf, p94, v-Raf murine sarcoma viral oncogene homolog B1
Anti-BRAF antibody [EP152Y] (ab33899) is a rabbit monoclonal antibody that is used to detect BRAF in Western Blot, IP, IHC-P. Suitable for Human, Mouse, Rat samples.
- Specificity confirmed with BRAF knockout cell line validation
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
The mouse and rat recommendation is based on the WB results. We do not guarantee IHC-P for mouse and rat.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
ab33899 (unpurified) staining B Raf cells from human prostate tissue by immunohistochemistry (formalin/PFA-fixed paraffin-embedded sections). Cells were formaldehyde fixed and permeabilized in PBS-Tween 20 prior to blocking in 70% serum for 10 minutes at 25°C. The primary antibody was diluted 1/250 and incubated with the sample for 1 hour at 25°C. A biotin conjugated goat polyclonal to mouse Ig was used as the secondary.
ab33899 was shown to react with BRAF in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line Human BRAF knockout HeLa cell line ab265373 (knockout cell lysate Human BRAF knockout HeLa cell lysate ab257078) was used. Wild-type HeLa and BRAF knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab33899 and Anti-GAPDH antibody [6C5] - Loading Control (Anti-GAPDH antibody [6C5] - Loading Control ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/1000 dilution
Lane 1: Wild-type HeLa cell lysate at 20 µg
Lane 2: BRAF knockout HeLa cell lysate at 20 µg
Performed under reducing conditions.
Predicted band size: 84 kDa
Observed band size: 90 kDa
ab33899 (Purified) at 1/20 dilution (20 μg/ml) immunoprecipitating BRAF in HeLa whole cell lysate.
Lane 1 (input): HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 10 μg
Lane 2 (+): ab33899 & HeLa whole cell lysate
Lane 3 (-): Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab33899 in HeLa whole cell lysate
For western blotting, ab33899 at 1/500 and VeriBlot for IP secondary antibody (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) was used as the secondary antibody at 1/1000 dilution.
Blocking and diluting buffer: 5% NFDM /TBST .
All lanes: Immunoprecipitation - Anti-BRAF antibody [EP152Y] (ab33899)
Predicted band size: 84 kDa
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human breast cancer tissue sections labeling BRAF with purified ab33899 at 1/100 dilution (4.77 μg/ml). Heat mediated antigen retrieval was performed using heat mediated antigen retrieval using Antigen Retrieval Buffer (100X Tris-EDTA Buffer, pH 9.0) ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control: PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
ab33899 was shown to recognize B Raf in wild-type HAP1 cells as signal was lost at the expected MW in B Raf knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and B Raf knockout samples were subjected to SDS-PAGE. ab33899 and Anti-GAPDH antibody [6C5] - Loading Control ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/1000 dilution
Lane 1: Wild-type HAP1 whole cell lysate at 40 µg
Lane 2: BRAF knockout HAP1 whole cell lysate at 40 µg
Lane 3: HeLa whole cell lysate at 40 µg
Predicted band size: 84 kDa
All lanes: Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/5000 dilution
All lanes: PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates at 15 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 84 kDa
Observed band size: 87 kDa
All lanes: Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/2000 dilution
Lane 1: HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 15 µg
Lane 2: Mouse brain lysates at 15 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 84 kDa
Observed band size: 87 kDa
This image shows paraffin embedded human prostate cancer tissue sample stained with ab33899 (unpurified) at 1/250 dilution.
All lanes: Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/5000 dilution
All lanes: HeLa cell lysate
Predicted band size: 84 kDa
Observed band size: 87 kDa
All lanes: Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/1000 dilution
Lane 1: Lysate prepared from mouse brain
Lane 2: Lysate prepared from mouse heart
Lane 3: Lysate prepared from mouse kidney
Lane 4: Lysate prepared from mouse spleen
Lane 5: Lysate prepared from rat brain
Lane 6: Lysate prepared from rat heart
Lane 7: Lysate prepared from rat kidney
Lane 8: Lysate prepared from rat spleen
Predicted band size: 84 kDa
Exposure time: 3min
Blocking and diluting buffer and concentration: 5% NFDM/TBST
The band below 90 kDa in lane 1 may be caused by degradation.
Lysates were freshly made and used immediately to minimize protein degradation.
In Western blot, anti-GAPDH antibody (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) loading control staining at 1/200000 dilution.
Anti-BRAF antibody (ab33899) total protein control staining at 1/1000 dilution.
Exposure time: Lane 1, 2: 3 minutes; Lane 3, 4: 15 seconds
All lanes: Western blot - Anti-BRAF (phospho S446) antibody [EPR28069-63] (Anti-BRAF (phospho S446) antibody [EPR28069-63] ab313793) at 1/1000 dilution
Lane 1: NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (untreated membrane) at 20 µg
Lane 2: NIH/3T3 whole cell lysate (phosphatase treated membrane) at 20 µg
Lane 3: PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate (untreated membrane) at 20 µg
Lane 4: PC-12 whole cell lysate (phosphatase treated membrane) at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 90 kDa
BRAF Western blot staining using rabbit Anti-BRAF antibody
Blocking and diluting buffer and concentration: 5% NFDM/TBST
The bands below 90 kDa in lane 1 may be caused by degradation. Lysates were freshly made and used immediately to minimize protein degradation.
In Western blot, anti- Vinculin antibody (Anti-Vinculin antibody [EPR8185] - Loading Control ab129002) loading control staining at 1/10000 dilution.
Anti-BRAF antibody (ab33899) total protein control staining at 1/1000 dilution.
Exposure time: 3 minutes
All lanes: Western blot - Anti-BRAF (phospho S446) antibody [EPR28069-63] (Anti-BRAF (phospho S446) antibody [EPR28069-63] ab313793) at 1/1000 dilution
Lane 1: Wild-type HAP1(human chronic myelogenous leukemia near-haploid cell line) whole cell lysate (untreated membrane) at 20 µg
Lane 2: BRAF knockout HAP1 whole cell lysate (untreated membrane) at 20 µg
Lane 3: Wild-type HAP1 whole cell lysate (phosphatase treated membrane) at 20 µg
Lane 4: BRAF knockout HAP1 whole cell lysate (phosphatase treated membrane) at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 90 kDa
Exposure time: 3min
Image collected and cropped by CiteAb under a CC-BY license from the publication
BRAF western blot using anti-BRAF antibody [EP152Y] ab33899. Publication image and figure legend from Zhang, H., Zheng, D., et al., 2016, Sci Rep, PubMed 27767059.
ab33899 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab33899 please see the product overview.
Compounds 1, 2, and 9 downregulate RAF-MAPK signaling pathway and snail protein level.RAS-RAF-MEK-ERK cascades and snail protein were analyzed by western blot. TE1 cells were treated with 1, 2, or 9 with various concentrations (0, 10, 20 μM) for 48 h. Sorafenib (SFB) was used as the positive control.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com